By Shawn Magsig, on January 6th, 2012
A new caffeine mist is being marketed as “breathable energy” and comes in a lipstick-size tube. It is currently being sold for $2.99 per tube in New York and Boston area stores.
This caffeine mist, called Aeroshot Pure Energy, is designed to spray a mist of caffeine and B vitamins that will dissolve in . . . → Read More: Caffeine: A Club Drug?
By Jim Plutchak, on January 4th, 2012
This link provides an excellent primer on Pain Management. Particularly interesting is the fact that Pain Management can be traced back to 4000 BC…the more things change, they more they stay the same.
What is Pain Management
Follow @utaklabs . . . → Read More: What is Pain Management?
By Jim Plutchak, on December 29th, 2011
Hello? Is there anybody in there? Just nod if you can hear me. Is there anyone at home? Come on, now, I hear you’re feeling down. Well I can ease your pain And get you on your feet again…
Comfortably Numb, by Pink Floyd
A recent CBS News report stated that four pharmaceutical companies . . . → Read More: Zohydro: Comfortably Numb in 2012
By Ashley Metcalf, on December 28th, 2011
Mephedrone, Methylenedioxypyrovalerone (MDPV), and Methylone are the active ingredient in Bath Salts.
Bath Salts are reportedly manufactured in China and are chemically similar to the cathinone compounds found in the khat plant of eastern Africa. It comes in the form of tablets or a powder, which users can swallow, snort or inject, producing similar . . . → Read More: Drug Information on Bath Salts
By Shawn Magsig, on December 28th, 2011
Since March of 2011, sixteen deaths in Ohio have been linked to synthetic stimulants commonly referred to as Bath Salts. Local officials say the designer drug remains a problem in the region despite a statewide ban that went into effect in October.
Laureen Marinetti, Chief Forensic Toxicologist for the Montgomery County Coroner’s Office and . . . → Read More: Bath Salts: A New and Deadly Designer Drug
By Tim Nelson, on December 19th, 2011
Everolimus, sold as Afinitor by Novartis AG, is the 40-O-(2-hydroxyethyl) derivative of Sirolimus and works similarly to Sirolimus as an mTOR inhibitor. Currently, Everolimus is effectively used as an immunosuppressant drug to prevent rejection of organ transplants.
However, in a recent study, women with advanced stages of breast cancer were treated with Everolimus. . . . → Read More: Immunosuppressant Drugs: The Many Uses of Everolimus
By Jim Plutchak, on December 12th, 2011
Ten years ago Eric Schlosser wrote a book titled, Fast Food Nation: The Dark Side of the All-American Meal.
This bestseller examined the local and global influence of the United States fast food industry. In a nutshell, Schlosser suggested that American obesity was a disturbing new epidemic which could be directly linked to . . . → Read More: Pain Food Nation: The Dark Side of OxyContin
By Jim Plutchak, on December 7th, 2011
The American Association of Clinical Chemistry (AACC) offers a number of thought-provoking online programs that provide training in selected areas of laboratory medicine. This Vitamin D webinar is very timely as new research is not only shedding light on the prevalence of Vitamin D deficiency but also the enormous health benefits of maintaining . . . → Read More: An Update on Clinical Applications for Vitamin D Assays
By Luba Soldatova, on December 6th, 2011
The UTAK Control Freaks have added Lacosamide to its Antiepileptic Drug Controls, so we thought it would be fun to share some of Lacosamide’s pharmacological characteristics.
Therapeutic Drug Monitoring (TDM) of Lacosamide is important to individualize patient therapy, determine base line levels, and confirm patient compliance. The optimal concentration range is 1 – . . . → Read More: Antiepileptic Drug Testing: Lacosamide, an Anticonvulsant and a Pain Killer
By Ashley Metcalf, on December 2nd, 2011
This short article examines the effects of lead exposure on obesity and bone loss.
National Institute of Environmental Health Sciences
Follow the link for information about UTAK’s Whole Blood Lead Controls.
Follow @utaklabs
|
Subscribe
|